why choose us

First received: September 04, 2023

Clinical Trial: Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Placebo-Controlled Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Multiple Ascending Subcutaneous Doses of GS

Brief Summary: The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).The primary objectives of this study are to assess the safety and tolerability of multiple ascending subcutaneous (SC) doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple SC doses of GS-0272, in participants with RA or SLE.

Read more